Distinguished in Febrile Neutropenia

Ruth Pettengell

St. George's University Of London, 
London, ENG, GB 
Distinguished in Febrile Neutropenia
St. George's University Of London, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Ruth Pettengell practices in London, United Kingdom. Ms. Pettengell is rated as a Distinguished expert by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Febrile Neutropenia, Non-Hodgkin Lymphoma, Agranulocytosis, Follicular Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 65 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 7 articles in the study of Febrile Neutropenia.

Gender
Female

Locations

St. George's University Of London, London, ENG, United Kingdom
Other Locations
1st Floor, 5 St Philip's Place, Birmingham, ENG, United Kingdom
Kings College London Hospitals NHS Foundation Trust Denmark Hill
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Study of Nivolumab Monotherapy in Patients With Relapsed/Refractory Hodgkin Lymphoma Fit for Autologous Stem Cell Transplant Who Fail to Reach Complete Metabolic Remission After First or Second Line Salvage Therapy
A Phase II Study of Nivolumab Monotherapy in Patients With Relapsed/Refractory Hodgkin Lymphoma Fit for Autologous Stem Cell Transplant Who Fail to Reach Complete Metabolic Remission After First or Second Line Salvage Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2023
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 2
A Comparison of Exercise Training With Relaxation Intervention in Lymphoma Patients Post-chemotherapy.
A Comparison of Exercise Training With Relaxation Intervention in Lymphoma Patients Post-chemotherapy.
Enrollment Status: Completed
Publish Date: February 20, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
View 2 Less Clinical Trials

65 Total Publications

Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.
Journal: British journal of haematology
Published: November 23, 2021

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Pettengell's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile